Share on StockTwits

Examworks Group (NASDAQ:EXAM)‘s stock had its “buy” rating reaffirmed by Deutsche Bank in a research note issued on Friday. They currently have a $40.00 price objective on the stock, up from their previous price objective of $38.00. Deutsche Bank’s price target suggests a potential upside of 32.85% from the stock’s previous close.

Examworks Group (NASDAQ:EXAM) traded up 4.05% on Friday, hitting $31.33. 107,353 shares of the company’s stock traded hands. Examworks Group has a 52-week low of $21.91 and a 52-week high of $38.61. The stock’s 50-day moving average is $30.65 and its 200-day moving average is $32.45. The company’s market cap is $1.207 billion.

Examworks Group (NASDAQ:EXAM) last released its earnings data on Tuesday, May 6th. The company reported ($0.01) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.03) by $0.02. The company had revenue of $173.00 million for the quarter, compared to the consensus estimate of $166.64 million. During the same quarter last year, the company posted ($0.10) earnings per share. Examworks Group’s revenue was up 16.3% compared to the same quarter last year. Analysts expect that Examworks Group will post $0.19 EPS for the current fiscal year.

A number of other analysts have also recently weighed in on EXAM. Analysts at Needham & Company LLC cut their price target on shares of Examworks Group from $43.00 to $38.00 in a research note on Tuesday, June 10th. They now have a “buy” rating on the stock. Finally, analysts at Zacks upgraded shares of Examworks Group from a “neutral” rating to an “outperform” rating in a research note on Wednesday, April 30th. They now have a $40.70 price target on the stock.

ExamWorks Group, Inc (NASDAQ:EXAM) is a provider of independent medical examinations (IMEs), peer and bill reviews, and related services, referred to as IME services or the IME industry.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.